Showing results (51-60 of 505) with videos related to
Sort By:
Pageof 51
Annual Review of Medicine|January 22, 2005
New anticoagulant therapyLori-Ann Linkins, Jeffrey I WeitzBritish Journal of Haematology|June 29, 2006
The status of new anticoagulantsShannon M Bates, Jeffrey I WeitzExpert Opinion on Investigational Drugs|February 17, 2007
Beyond heparin and warfarin: the new generation of anticoagulantsJeffrey I Weitz, Lori-Ann LinkinsHamostaseologie|April 16, 2021
Factor XI as a Target for New AnticoagulantsJames C Fredenburgh, Jeffrey I WeitzArteriosclerosis, Thrombosis, and Vascular Biology|August 31, 2023
New Therapeutic Targets for the Prevention and Treatment of Venous Thromboembolism With a Focus on Factor XI InhibitorsNoel C Chan, Jeffrey I WeitzFrontiers in Medicine|March 14, 2017
Factors XI and XII as Targets for New AnticoagulantsJeffrey I Weitz, James C FredenburghJournal of Thrombosis and Thrombolysis|November 3, 2009
Update on heparin: what do we need to know?Daniel S Weitz, Jeffrey I WeitzCurrent Pharmaceutical Design|November 25, 2005
Pharmacology and clinical potential of direct thrombin inhibitorsLori-Ann Linkins, Jeffrey I WeitzArteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2018
Advances in Antithrombotic TherapyJeffrey I Weitz, Noel C ChanArteriosclerosis, Thrombosis, and Vascular Biology|December 23, 2017
2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New AnticoagulantsJeffrey I Weitz, James C FredenburghPageof 51